Login to Your Account



Alkermes' Alcohol Dependence Drug Vivitrex On File With FDA

By Aaron Lorenzo


Monday, April 4, 2005
Alkermes Inc. applied for FDA approval of Vivitrex (naltrexone long-acting injection) to treat alcoholism, making it the first injectable product filed for the indication. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription